Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
171.00    2.60 (1.54%)
Bid:
171.20
Ask:
171.80
Spread: 0.60 (0.35%)
Market Cap: £416.08m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Director/PDMR Shareholding

21 Jun 2018 14:00

RNS Number : 1536S
Sabre Insurance Group PLC
21 June 2018
Β 

21 June 2018

Β 

Sabre Insurance Group plc ("Sabre" or the "Company")

Notification of transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

Β 

Further to the approval of the Company's directors' remuneration policy at the 2018 AGM, Sabre announces that today the following directors and PDMRs of the Company were, subject to the rules of the Sabre 2017 Long-Term Incentive Plan (the "Plan"), each granted a conditional award of ordinary shares of 0.001p in the Company as detailed below:

Name

Position

No of shares subject to award

Geoff Carter

Chief Executive Officer

186,289

Adam Westwood

Chief Financial Officer

83,830

Trevor Webb

Claims Director

102,459

James Ockenden

Chief Actuary

93,144

Anneka Kingan

Company Secretary

29,806

Β 

The vesting of the awards will be subject to the achievement of performance conditions measuring the Company's total shareholder return performance (relative to the constituent companies of the FTSE250 index (excluding investment trusts and companies in the extractive industries)) and earnings per share performance, both measured over a period from 1 January 2018 to 31 December 2020.

Β 

This notification is made pursuant to Article 19 of the EU Market Abuse Regulation.

Additional Information:

Anneka Kingan - Company Secretary

Anneka.kingan@sabre.co.ukΒ 

Β 

Β 

PDMR transaction notification

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Geoff Carter

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Executive Officer

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Β 

Grant of conditional award

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

Β£2.68

186,289

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

186,289

Β£2.68

Β 

e)

Date of transaction

21 June 2018

f)

Place of transaction

London Stock Exchange (XLON)

Β 

Β 

Β 

Β 

Β 

PDMR transaction notification

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Adam Westwood

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Financial Officer

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Β 

Grant of conditional award

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

Β£2.68

83,830

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

83,830

Β£2.68

Β 

e)

Date of transaction

21 June 2018

f)

Place of transaction

London Stock Exchange (XLON)

Β 

Β 

Β 

Β 

PDMR transaction notification

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Trevor Webb

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Claims Director

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Β 

Grant of conditional award

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

Β£2.68

102,459

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

102,459

Β£2.68

Β 

e)

Date of transaction

21 June 2018

f)

Place of transaction

London Stock Exchange (XLON)

Β 

Β 

Β 

Β 

PDMR transaction notification

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

James Ockenden

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Actuary

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Β 

Grant of conditional award

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

Β£2.68

93,144

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

93,144

Β£2.68

Β 

e)

Date of transaction

21 June 2018

f)

Place of transaction

London Stock Exchange (XLON)

Β 

Β 

Β 

Β 

Β 

PDMR transaction notification

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Anneka Kingan

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Company Secretary

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Β 

Grant of conditional award

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

Β£2.68

29,806

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

29,806

Β£2.68

Β 

e)

Date of transaction

21 June 2018

f)

Place of transaction

London Stock Exchange (XLON)

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHBFLFLVQFLBBZ
Date   Source Headline
11th Jul 202412:25 pmRNSDirector/PDMR Shareholding
3rd Jul 20243:40 pmRNSHolding(s) in Company
19th Jun 202412:28 pmRNSAppointment of Non-executive Director
14th Jun 20249:50 amRNSDirector/PDMR Shareholding
11th Jun 202411:54 amRNSDirector/PDMR Shareholding
11th Jun 202410:17 amRNSDirector/PDMR Shareholding
10th Jun 20244:16 pmRNSHolding(s) in Company
6th Jun 202412:52 pmRNSDirector/PDMR Shareholding
30th May 20242:00 pmRNSDirector/PDMR Shareholding
23rd May 202411:08 amRNSResult of AGM
23rd May 20247:00 amRNSTrading Update
22nd May 20241:59 pmRNSDirector/PDMR Shareholding
21st May 20242:46 pmRNSHolding(s) in Company
20th May 20248:23 amRNSAppointment of Senior Independent Director
15th May 20242:24 pmRNSHolding(s) in Company
13th May 202412:23 pmRNSDirector/PDMR Shareholding
23rd Apr 20244:00 pmRNSHolding(s) in Company
22nd Apr 20243:22 pmRNSHolding(s) in Company
19th Apr 20248:51 amRNSChair Appointment
18th Apr 202411:22 amRNSDirector Declaration
11th Apr 202412:41 pmRNSDirector/PDMR Shareholding
11th Apr 202412:07 pmRNSDirector/PDMR Shareholding
9th Apr 20242:44 pmRNSDirector/PDMR Shareholding
5th Apr 20243:48 pmRNSNotice of AGM
21st Mar 202412:30 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFull-year results 2023
13th Mar 20249:33 amRNSNotice of Results
12th Mar 20242:16 pmRNSDirector/PDMR Shareholding
12th Mar 202412:14 pmRNSDirector Declaration
16th Feb 20241:52 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTrading Statement
13th Feb 20242:18 pmRNSDirector/PDMR Shareholding
11th Jan 202411:11 amRNSDirector/PDMR Shareholding
20th Dec 20232:24 pmRNSHolding(s) in Company
12th Dec 202312:03 pmRNSDirector/PDMR Shareholding
28th Nov 20234:27 pmRNSDirectorate Change
27th Nov 20234:42 pmRNSRemuneration Committee Chair Appointment
22nd Nov 20238:51 amRNSNotification of cyber incident
20th Nov 20237:00 amRNSDeath of Chair
13th Nov 202311:44 amRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSTrading Update
11th Oct 202312:52 pmRNSDirector/PDMR Shareholding
25th Sep 20233:39 pmRNSDirector/PDMR Shareholding
21st Sep 202311:48 amRNSDirector/PDMR Shareholding
14th Sep 20232:25 pmRNSHolding(s) in Company
13th Sep 202310:00 amRNSDirector/PDMR Shareholding
13th Sep 20239:33 amRNSDirectorate Change
11th Aug 202310:07 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSHalf-year Report 2023
25th Jul 20238:53 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.